An2 Therapeutics, Inc. Share Price

NASDAQ: ANTX

Small Cap

$1.28

+0.01

(+0.79%)

as on September 13, 2025 at 1:28 am IST

$₹

An2 Therapeutics, Inc. Stock Performance

as on September 13, 2025 at 1:28 am IST

Day's Low
Day's High
$1.25
Day's Price Range
$1.33
$1.28
2.34%
Downside
3.91%
Upside
52 Week's Low
52 Week's High
$0.98
52-Week Price Range
$1.68
$1.28
23.83%
Downside
30.86%
Upside

An2 Therapeutics, Inc. share price movements today

Previous Close: $1.27
Open: $1.27
Volume: 586.7K
Day's Low - High: $1.25 - $1.33
52 Week Low - High: $0.98 - $1.68

An2 Therapeutics, Inc. Historical Returns

1 Month Return: + 21.9 %
3 Month Return: + 19.63 %
1 Year Return: + 23.08 %
3 Year Return: -84.74 %
5 Year Return: 0 %

An2 Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check An2 Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$34.7M

EPS (TTM)

-1.01

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

6704100.00%

An2 Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of An2 Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
An2 Therapeutics, Inc.	BUY	$34.7M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for An2 Therapeutics, Inc. Stock including INR - Dollar returns

The An2 Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

An2 Therapeutics, Inc. investment value today

Current value as on today

₹1,28,216

Returns

₹28,216

(+28.22%)

Returns from An2 Therapeutics, Inc. Stock

₹23,077 (+23.08%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on An2 Therapeutics, Inc. Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for An2 Therapeutics, Inc.. Average target price of $1.5

An2 Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on An2 Therapeutics, Inc..

What analysts predicted

14.67%UPSIDE

Target Price

$1.5

Current Price

$1.28

Analyzed by

11 Analysts

Target

$1.50

An2 Therapeutics, Inc. target price $1.5, a slight upside of 14.67% compared to current price of $1.28. According to 11 analysts rating.

An2 Therapeutics, Inc. Stock's Interest Amongst Investors

Search interest for An2 Therapeutics, Inc. Stock has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 15, 2025 to September 14, 2025

Change:-61% versus previous 30 day period

An2 Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	0	-	-	-	-	-
Gross Profit	0	0	-	0	0	-	-	-	-	-
Operating Income	-16	-16	-18	-18	-18	-15	-14	-8	-11	-7
EBITDA	-16	-16	-18	-16	-15	-15	-11	-7	-11	-7
Interest Expense	0	-	-	0	0	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-15	-15	-16	-16	-16	-14	-12	-7	-10	-6
Income Tax Expense	0	0	0	0	-18	-15	-	-	-	-
Net Income	-14	-15	-16	-16	-16	-14	-12	-7	-10	-6
Net Profit Margin	0.00%	0.00%	0.00%	-21122.50%	-20771.25%	0.00%	0.00%	0.00%	0.00%	0.00%

An2 Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	-	-	0	-	-
Operating Income	-7	-21	-42	-69	-54
EBITDA	-7	-21	-43	4	-51
Interest Expense	0	0	0	-	-
Depreciation	-	-	-	-	-
Income Before Tax	-13	-21	-40	-64	-51
Income Tax Expense	0	0	0	0	-
Net Income	-13	-21	-41	-64	-51
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

An2 Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-15	-16	-16	-16	-14	-12	-7	-10	-6
Operating Cash Flow	-12	-11	-17	-17	-14	-12	-5	-10	-7
Investing Cash Flow	7	-62	0	26	16	18	-6	9	5
Financing Cash Flow	19	66	0	0	-	0	-	0	-
Change in Cash	14	-8	-16	9	2	6	-12	-1	-1

An2 Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-13	-21	-40	-64	-51
Operating Cash Flow	-5	-20	-33	-53	-49
Investing Cash Flow	-50	-50	-21	-43	54
Financing Cash Flow	3	78	70	84	0
Change in Cash	-1	8	15	-11	5

Global Institutional Holdings in An2 Therapeutics, Inc.

Funds	Holdings
BML Capital Management LLC	19.1%
Almitas Capital LLC	4.36%
Vanguard Group Inc	3.44%
Adage Capital Partners Gp LLC	3.32%
Pfizer Inc	2.38%

See all

Insights on An2 Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, ANTX stock has moved up by 22.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 210.2%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 51.7%

About An2 Therapeutics, Inc.

an2 therapeutics, inc. is a california-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. an2 is a mission-driven company, with a vision for humanity to be free from the threat of infectious diseases by addressing the urgent need for new treatments that can save lives across the globe. founded by a small team of biopharmaceutical industry leaders with a passion for global health and experience in infectious disease drug r&d, we strive to bring patients treatments that will restore their health and enable them to live productive lives.

Organisation	An2 Therapeutics, Inc.
Headquarters	1800 El Camino Real, Menlo Park, CA, United States, 94027
Industry	Services
CEO	Mr. Eric E. Easom
E-voting on shares	Click here to vote

Key Management of An2 Therapeutics, Inc.

Name	Title
Mr. Joshua M. Eizen J.D.	Chief Legal Officer, COO & Corporate Secretary
Dr. George Harrison Talbot FACP, M.D.	Co-Founder & Senior Clinical Advisor
Mr. Eric E. Easom	Co-Founder, CEO, President & Chairman of the Board
Ms. Lucy O. Day CPA	CFO, Principal Financial Officer & Principal Accounting Officer
Dr. Sanjay Chanda Ph.D.	Chief Development Officer
Dr. Stephen David Prior Ph.D.	Chief Strategy Officer
Mr. Vince Hernandez	Senior VP of Research & Head of Chemistry
Mr. Joseph S. Zakrzewski	Co-Founder & Independent Chairman of the Board
Dr. Michael R. K. Alley Ph.D.	Co-Founder, Senior VP of Research Fellow & Head of Biology

FAQs

What is An2 Therapeutics, Inc. share price today?

An2 Therapeutics, Inc. share price today is $1.28 as on September 13, 2025 at 1:28 am IST at the close of the market. An2 Therapeutics, Inc. share today touched a day high of $1.33 and a low of $1.25.

What is the 52 week high and 52 week low for An2 Therapeutics, Inc. share?

An2 Therapeutics, Inc. share touched a 52 week high of $1.68 on November 29, 2024 and a 52 week low of $0.98 on November 18, 2024. An2 Therapeutics, Inc. stock price today i.e. September 13, 2025 at 1:28 am IST is closed at $1.28,which is 23.58% down from its 52 week high and 31.28% up from its 52 week low.

What is An2 Therapeutics, Inc.'s market capitalisation today?

An2 Therapeutics, Inc. market capitalisation is $0.00T as on September 13, 2025 at 1:28 am IST.

How to invest in An2 Therapeutics, Inc. Stock (ANTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for An2 Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in An2 Therapeutics, Inc. Shares that will get you 1.1719 shares as per An2 Therapeutics, Inc. share price of $1.28 per share as on September 13, 2025 at 1:28 am IST.

What is the minimum amount required to buy An2 Therapeutics, Inc. Stock (ANTX) from India?

Indian investors can start investing in An2 Therapeutics, Inc. (ANTX) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 5:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in An2 Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 5:42 am IST). Based on An2 Therapeutics, Inc. share’s latest price of $1.28 as on September 13, 2025 at 1:28 am IST, you will get 7.8125 shares of An2 Therapeutics, Inc.. Learn more about fractional shares .